Product Information
Relacorilant is a drug that inhibits the production of epidermal growth factor (EGF). This drug has been shown to be effective in the treatment of adrenocortical carcinoma. Relacorilant is given to patients in a dose-dependent manner, with low doses being more effective than high doses. Relacorilant has been shown to have an anti-tumor effect in vitro and in vivo, which may be due to its inhibition of EGFR activity on cell signaling pathways.
Chemical properties
Technical inquiry about: 3D-WJC51051 Relacorilant
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.